Log In
BCIQ
Print this Print this
 

PR022

  Manage Alerts
Collapse Summary General Information
Company Realm Therapeutics plc
DescriptionHigh dose concentration of hypochlorous acid
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationDermatitis
Indication DetailsTreat atopic dermatitis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today